These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 9300314)

  • 1. In vivo Assessment of Combined Effects of Glibenclamide and Losartan in Diabetic Rats.
    Alotaibi MR; Fatani AJ; Almnaizel AT; Ahmed MM; Abuohashish HM; Al-Rejaie SS
    Med Princ Pract; 2019; 28(2):178-185. PubMed ID: 30537701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
    Sudhir K; MacGregor JS; Gupta M; Barbant SD; Redberg R; Yock PG; Chatterjee K
    Circulation; 1993 Mar; 87(3):931-8. PubMed ID: 8383016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
    Yamamoto M; Egashira K; Arimura K; Tada H; Shimokawa H; Takeshita A
    Jpn Circ J; 2000 Sep; 64(9):701-7. PubMed ID: 10981856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K(ATP)(+) channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation.
    Tune JD; Richmond KN; Gorman MW; Feigl EO
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H868-75. PubMed ID: 11158988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade.
    Duncker DJ; van Zon NS; Pavek TJ; Herrlinger SK; Bache RJ
    J Clin Invest; 1995 Jan; 95(1):285-95. PubMed ID: 7814627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea.
    Davis CA; Sherman AJ; Yaroshenko Y; Harris KR; Hedjbeli S; Parker MA; Klocke FJ
    J Am Coll Cardiol; 1998 Mar; 31(4):816-22. PubMed ID: 9525553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
    Tada H; Egashira K; Yamamoto M; Ueno H; Takemoto M; Shimokawa H; Takeshita A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):313-9. PubMed ID: 9300314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.
    Ishibashi Y; Duncker DJ; Zhang J; Bache RJ
    Circ Res; 1998 Feb; 82(3):346-59. PubMed ID: 9486663
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.